Literature DB >> 32533338

A 9-year-old girl with Kawasaki disease and pulmonary nodules.

Yousuke Higuchi1, Motoharu Ochi2, Junya Shimizu2, Mahoko Furujo2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32533338      PMCID: PMC7290145          DOI: 10.1007/s10067-020-05222-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


× No keyword cloud information.

Presentation

A 9-year-old girl was referred for low-grade fever, posterior cervical pain, maculopapular rash, erythema of pharyngeal mucosa, and bilateral conjunctival injection on 28 January 2020. The remaining examination was unremarkable, including auscultation, meningeal irritation signs, cervical lymphadenopathy, and extremity changes. She and her family had no travel history. Laboratory data showed slightly elevated white blood cell (WBC) count 9.7 × 109/L and C-reactive protein (CRP) levels 3.3 mg/L. She scheduled a follow-up visit for 3 days’ time but returned later that evening complaining of chest pain. A chest radiograph showed no apparent findings, and she went home. The next day, she revisited our hospital due to a high-grade fever, neck pain, and cough. Rapid antigen tests for group A streptococcus, adenovirus, and influenza A/B were negative. Repeated blood tests showed elevated WBC count 13.4 × 109/L and CRP levels 82.0 mg/L; therefore, she was admitted for further examination. Contrast-enhanced computed tomography (CT) on the second hospital day revealed no abnormalities in the neck region, but pulmonary nodules, pleural and pericardial effusion, and gallbladder hydrops were identified (Fig. 1a). Serum antibodies against Epstein-Bar virus, cytomegalovirus, and parvovirus B19 showed uninfected pattern. Blood culture and cryptococcal half quantity test were negative. Therefore, she was diagnosed with an incomplete Kawasaki disease (KD). We administrated intravenous immunoglobulin single-dose 2 g/kg and aspirin 50 mg/kg/day and her symptoms and laboratory results rapidly improved. Her pericardial effusion gradually decreased, with no coronary artery abnormalities detected. On the thirteenth hospital day, follow-up CT resolved the findings (Fig. 1b), and serum mycoplasma pneumoniae particle agglutination antibody titer was not elevated.
Fig. 1

a CT scan of the chest abdomen showed pulmonary nodules with a halo sign, pleural and pericardial effusion, and acalculous gallbladder hydrops. b Twelve-day follow-up CT showed the disappearance of pulmonary nodules and fluid retention

a CT scan of the chest abdomen showed pulmonary nodules with a halo sign, pleural and pericardial effusion, and acalculous gallbladder hydrops. b Twelve-day follow-up CT showed the disappearance of pulmonary nodules and fluid retention

Discussion

Pulmonary nodules are described as sub-symptom in the American Heart Association scientific statement on KD, as well as pericarditis and gallbladder hydrops [1]. There have only been seven reported cases of infants affected by pulmonary nodules associated with KD, all of which also presented with coronary artery involvement [2-5]. Histological study of the nodules showed inflammatory-cell infiltration as is seen in coronary artery aneurysms in patients with KD [2]. Rapid involution of pulmonary nodules via standard KD treatment may reflect the inflammatory nature of the lesions. We believe that the involvement of severe acute respiratory syndrome coronavirus 2 was quite low because she was brought to our hospital in late January 2020 when the coronavirus disease epidemic was not yet in Japan. KD should also be considered as a differential diagnosis in patients presenting with acute febrile illness with pulmonary nodules, even in older children.
  5 in total

1.  Prolonged fever with pulmonary nodules in a 4-month-old baby.

Authors:  Mohamad H Itani; Ramia G Zakhour; Maurice C Haddad; Mariam T Arabi
Journal:  Pediatr Infect Dis J       Date:  2010-08       Impact factor: 2.129

Review 2.  Kawasaki disease with pulmonary nodules and coronary artery involvement: a report of two cases and a review of the literature.

Authors:  Kentaro Akagi; Junya Abe; Kuniaki Tanaka; Seiichi Tomotaki; Yoichi Iki; Kazutoshi Ueda; Masatoshi Nakata; Takakazu Yoshioka; Mitsutaka Shiota; Atsuko Hata; Ken Watanabe; Daisuke Hata
Journal:  Int J Rheum Dis       Date:  2015-07-22       Impact factor: 2.454

3.  [Radiologic findings in the lungs of patients with Kawasaki disease].

Authors:  María Dolores Monedero Picazo; Jacinto Gómez Fernández-Montes; Rubén Molina Fábrega; Amparo Vallcanera Calatayud; Guillermo Alabau Vázquez; María Amparo Revert Ros
Journal:  Radiologia       Date:  2006 Jan-Feb

Review 4.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.

Authors:  Brian W McCrindle; Anne H Rowley; Jane W Newburger; Jane C Burns; Anne F Bolger; Michael Gewitz; Annette L Baker; Mary Anne Jackson; Masato Takahashi; Pinak B Shah; Tohru Kobayashi; Mei-Hwan Wu; Tsutomu T Saji; Elfriede Pahl
Journal:  Circulation       Date:  2017-03-29       Impact factor: 29.690

5.  Inflammatory pulmonary nodules in Kawasaki disease.

Authors:  Alexandra F Freeman; Susan E Crawford; Laura S Finn; Juan A López-Andreu; Susana Ferrando-Monleón; Desamparados Pérez-Tamarit; Mona L Cornwall; Stanford T Shulman; Anne H Rowley
Journal:  Pediatr Pulmonol       Date:  2003-08
  5 in total
  2 in total

Review 1.  Kawasaki disease shock syndrome with acute respiratory distress syndrome in a child: a case report and literature review.

Authors:  Jingwei Liu; Chunfeng Yang; Zhen Zhang; Yumei Li
Journal:  BMC Pulm Med       Date:  2022-06-06       Impact factor: 3.320

Review 2.  Kawasaki disease and influenza-new lessons from old associations.

Authors:  Aaqib Zaffar Banday; Ashwini Arul; Pandiarajan Vignesh; Mini P Singh; Kapil Goyal; Surjit Singh
Journal:  Clin Rheumatol       Date:  2021-01-02       Impact factor: 2.980

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.